The dual burden of a pandemic
Medium US,
Anyone can publish on Medium per our Policies, but we don’t fact-check every story.
Anyone can publish on Medium per our Policies, but we don’t fact-check every story.
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for November 2019.
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for November 2019.
Here are what the editors at HealthDay consider to be the most important developments in Emergency Medicine for November 2019.
Here are what the editors at HealthDay consider to be the most important developments in Neurology for November 2019.
Here are what the editors at HealthDay consider to be the most important developments in Neurology for November 2019.
Here are what the editors at HealthDay consider to be the most important developments in Pathology for November 2019.
Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for November 2019.
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for November 2019.
Here are what the editors at HealthDay consider to be the most important developments in Diabetes
Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for November 2019.
Here are what the editors at HealthDay consider to be the most important developments in Neurology for November 2019.
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for November 2019.
WEDNESDAY, Nov. 13, 2019 (HealthDay News) -- People who inject drugs (PWID) have shorter survival following cardiac surgery…
ject drugs (PWID) have shorter survival following cardiac surgery than non-PWID, according to a review published online Nov.
About those suspected problems with unfractionated heparin dosing during cardiac procedures, FDA is interested in learning more…